The model for end-stage liver disease (MELD) score, a measure of how severe a patient’s liver disease is, and prothrombin time/international normalized ratio (PT/INR) were elevated in the high–CC1-L/CathG group (P = 0.006 and 0.013, respectively) (Supplemental Table 2). This evidence concerns the gene F2 and End Stage Liver Disease.